BRACE (UK): BCG Vaccination to reduce the impact of COVID-19 in healthcare workers

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-409

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    John L Campbell, Adilia Warris
  • Research Location

    United Kingdom, Australia
  • Lead Research Institution

    University of Exeter
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Health Personnel

Abstract

From the Centre website: The BRACE trial aims to recruit 10,000 healthcare workers who work in a healthcare setting or have face-to-face contact with patients in the UK, Australia, the Netherlands, Spain, and Brazil. The results of this trial will help us find out whether, in current and future novel viral outbreaks, BCG vaccination could be used as an early intervention to protect healthcare workers and other high-risk groups. In the UK, the trial is a collaboration between Exeter Medical School's Clinical Trials Unit and the Murdoch Children's Research Institute (MCRI) in Melbourne, Australia. Professor John Campbell, Professor of General Practice and Primary Care here in University of Exeter is the principal investigator in the UK for the BRACE trial, with Professor Adilia Warris, Co-Director of the MRC Centre for Medical Mycology and Professor in Paediatric Infectious Diseases, as deputy principal investigator.